Feedback / Questions
tregalizumab (BT-061) - ADMA Biologics, T-Balance Therapeutics
https://eaaci2023.process.y-congress.com/ScientificProcess/Data/67/386/Abstracts/db5df8c0564ae991d85091240f656e94.html
Stefan Zielen; Oguzhan Alemdar; Ruth Duecker; Lale Kayan; Andreas Wimmers; Johannes Schulze; Ralf Schubert
Apr 30, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next